glyburide has been researched along with l 158809 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, DY; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD | 1 |
| Egashira, K; Shimokawa, H; Tada, H; Takemoto, M; Takeshita, A; Ueno, H; Yamamoto, M | 1 |
2 other study(ies) available for glyburide and l 158809
| Article | Year |
|---|---|
Influence of N omega-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation.
Topics: Aminoquinolines; Angiotensin Receptor Antagonists; Animals; Arginine; Drug Interactions; Glyburide; Hypoxia; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasoconstriction | 1994 |
Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Coronary Circulation; Coronary Vessels; Dogs; Enzyme Inhibitors; Glyburide; Hypoglycemic Agents; Imidazoles; NG-Nitroarginine Methyl Ester; Potassium Channel Blockers; Pyridines; Tetrazoles; Vasodilation | 1997 |